Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Waxman (Boston, United States of America), Y. Fong (Raritan, United States of America), T. Jatkoe (Raritan, United States of America), H. Cheng (Singapore, Singapore), L. Zhou (Singapore, Singapore), C. Bridges (Boston , United States of America). Feasibility of microRNA signatures for detection early stage pulmonary hypertension. 1532

Member's Comments

No comment yet.

Related content which might interest you: Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Towards early detection of pulmonary hypertension: a call to arms Source: Eur Respir J 2014; 43: 16-19 Year: 2004 Proof of concept of a non-invasive screening tool to detect idiopathic pulmonary fibrosis (IPF) in an early stage Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018 Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort Source: Eur Respir J, 57 (6) 2002591; 10.1183/13993003.02591-2020 Year: 2021 CIPHER: a prospective, multicentre study for the identification of biomarker signatures for early detection of pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Systematic cardiac echoscreening is effective in detecting early stage pulmonary arterial hypertension in systemic sclerosis Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Evaluating the effects of pulmonary rehabilitation in patients with COPD in early and late disease stages. Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Improving identification and early referral of pulmonary hypertension patients Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Issues other than tissue: non-invasive biomarkers of early stage lung cancer Source: Virtual Congress 2020 – Will the pulmonologist still play a role in the management of screen-detected pulmonary nodules? Year: 2020 Early detection and management of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 306-312 Year: 2012 Evaluation of recently validated non-invasive formula using basic lung functions as a new screening tool for pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 A novel whole-blood miRNA signature for a rapid diagnosis of pulmonary tuberculosis Source: Eur Respir J 2015; 45: 1173-1176 Year: 2015 Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Screening for and early detection of COPD: feasibility and impact Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD” Year: 2009 Screening for biomarkers in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Identification of novel diagnostic biomarkers of chronic thromboembolic pulmonary hypertension using MALDI-TOF-MS Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 How to detect disease progression in pulmonary arterial hypertension Source: Eur Respir Rev 2012; 21: 40-47 Year: 2012